Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response. Medico Legal Update, [S. l.], v. 21, n. 1, p. 949–955, 2021. DOI: 10.37506/mlu.v21i1.2438. Disponível em: https://ijop.net/index.php/mlu/article/view/2438. Acesso em: 15 jun. 2026.